Donald A. Wuchterl insider trades: Abeona Therapeutics (ABEO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Donald reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | ABEO | ↓ Sell | 14,814 | $5.09 | $75K | Direct | Feb 2, 2026 (0d) |
| Jul 8, 2025 | ABEO | ↓ Sell10b5-1 | 5,176 | $5.82 | $30K | Direct | Jul 10, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ABEO insiders
Open-market trades in the last 12 months
About Donald A. Wuchterl's insider trades
Donald A. Wuchterl is a director at Abeona Therapeutics (ABEO). Since Jul 8, 2025, Donald has reported no open-market purchases and 2 sales worth $106K on SEC Form 4. In the last 12 months: 1 sale ($75K).
1 sale (29% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.